Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call Transcript November 7, 2024Ironwood Pharmaceuticals, Inc. misses on earnings expectations.
Ironwood Pharmaceuticals Inc (IRWD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 92,740,000 | $82,465,204 | +4% | 2.33% | |
| 2. | Sarissa Capital Management Alex Denner | 16,390,000 | $67,526,800 | 16.78% | |
| 3. | Renaissance Technologies Jim Simons | 8,597,198 | $35,420,456 | +1% | 0.05% |
| 4. | Armistice Capital Steven Boyd | 8,200,000 | $33,784,000 | +6% | 0.54% |
| 5. | 25,000,000 | $22,133,874 | 0.66% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.70 | 6,920 | 121,028 | 2024-03-06 | Filing | ||
| $9.38 | 10,684 | 301,733 | 2024-03-04 | Filing | ||
| $8.32 | 36,072 | Officer | 188,730 | 2023-09-15 | Filing | |
| $10.54 | 75,000 | Large Shareholder, Director | 16,390,000 | 2021-03-10 | Filing | |
| $10.30 | 150,000 | Large Shareholder, Director | 16,315,000 | 2021-03-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.08 | 5,360 | 284,685 | 2024-11-18 | Filing | ||
| $4.08 | 11,001 | 309,572 | 2024-11-18 | Filing | ||
| $4.27 | 9,910 | 284,661 | 2024-08-12 | Filing | ||
| $4.27 | 3,107 | 158,370 | 2024-08-12 | Filing | ||
| $6.29 | 22,766 | 139,528 | 2024-06-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 25,980,308 | $297,214,723 | 0% | |
| 2. | 16,033,545 | $183,423,755 | 0% | |
| 3. | 11,532,088 | $131,927,087 | 0% | |
| 4. | 5,612,113 | $64,202,573 | 0.06% | |
| 5. | 47,700,000 | $50,204,252 | 0.15% |
News See All
8 Penny Stocks with Biggest Upside Potential According to Analysts
The Federal Reserve slashed interest rates by a half point in September, kickstarting its first easing campaign in four years.
10 Best Multibagger Penny Stocks of 2025
The term "multibagger" was coined by Peter Lynch in his book titled "One Up On Wall Street" to describe those stocks whose share prices increase several times more than an investor's original investment...
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name, Celine, and I will be your conference operator today.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.08927 EPS, expectations were $0.18. Ironwood Pharmaceuticals, Inc.
5 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the five best low price pharma stocks to invest in.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.01 EPS, expectations were $0.2.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Aaron, and I will be your conference operator for today.
Top 5 Extreme Value Stocks To Buy
Donnelley Financial Solutions, Inc. (NYSE:DFIN) was the financial segment of R.R. Donnelley & Sons but was established as an independent corporation in 2016.
Hedge Fund and Insider Trading News: Cathie Wood, Steve Cohen, Ress Capital, Brevan Howard Asset Management, ExodusPoint Capital Management, CNX Resources Corp (CNX), Iovance Biotherapeutics, Inc. (IOVA), and More
Investors will flock to funds focusing on buzzy themes when the Federal Reserve cuts interest rates, according to Cathie Wood, who is doubling down on innovative investment strategies with a new acquisition...
Billionaire Hedge Funds
